GGrantIndex
Sort

25,944 grants matching neurodegeneration

Poor Sleep Altered Circadian Rhythms and Alzheimers Disease

$538,138
Adam Peter Spira · Johns Hopkins University · R01 · FY2017 · AG

Defining the induction and maintenance of myelin-specific tolerance in T cells and B cells using local lymph node depots

$538,057
Christopher M Jewell · Univ Of Maryland, College Park · R01 · FY2025 · AI

RNA binding proteins as novel targets in Alzheimer's disease

$538,004
Benjamin L Wolozin · Boston University Medical Campus · R01 · FY2017 · AG

Core F - Neuroimaging Core

$537,989
Howard J Rosen · University Of California, San Francisco · P30 · FY2025 · AG

Glucose metabolism, synaptic plasticity, and oxidative stress in Alzheimer's Disease

$537,936
Rajiv R Ratan · Winifred Masterson Burke Med Res Inst · P01 · FY2017 · AG

Glucose metabolism, synaptic plasticity, and oxidative stress in Alzheimer's Disease

$537,934
Rajiv R Ratan · Winifred Masterson Burke Med Res Inst · P01 · FY2020 · AG

Glucose metabolism, synaptic plasticity, and oxidative stress in Alzheimer's Disease

$537,934
Rajiv R Ratan · Winifred Masterson Burke Med Res Inst · P01 · FY2019 · AG

Efficacy of GluR5 Antogonists Against Soman-Induced Seizures and Neuropathology

$537,783
Maria F Braga · Henry M. Jackson Fdn For The Adv Mil/Med · U01 · FY2014 · NS

The consequences of the unusual mutation responsible for the Repeat Expansion Diseases

$537,584
Karen P. Usdin · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK

Evaluating microtubule binding as a potential imaging biomarker for Alzheimer's disease

$537,570
Kiran Solingapuram Sai · Wake Forest University Health Sciences · R01 · FY2024 · AG

BRAIN MRI &MRS CHANGES IN FIRST EPISODE SCHIZOPHRENIA

$537,561
University Of North Carolina Chapel Hill · R01 · FY2004 · MH

Mechanisms of Novel Regulators of Proteotoxicity and Quality Control Associated with ALS/FTD

$537,477
Jiou Wang · Johns Hopkins University · R01 · FY2022 · NS

Mechanisms of Novel Regulators of Proteotoxicity and Quality Control Associated with ALS/FTD

$537,477
Jiou Wang · Johns Hopkins University · R01 · FY2021 · NS

Quantitative Sodium MR Imaging and Proton MR Spectroscopy in Traumatic Brain Injury

$537,434
Ivan Ivanov Kirov · New York University School Of Medicine · R01 · FY2018 · NS

Topical drug delivery formulations for neuroprotection in glaucoma

$537,385
Laura Ensign · Johns Hopkins University · R01 · FY2025 · EY

Preventing and reversing mitochondrial Leigh syndrome with hypoxia

$537,347
Vamsi Krishna Mootha · Massachusetts General Hospital · R01 · FY2023 · NS

NEUROBIOLOGY

$537,325
Eliezer Masliah · University Of California, San Diego · P01 · FY2009 · DA

Diffusion Imaging Biomarkers for Risk, Onset and Outcome in Schizophrenia

$537,293
Marek Kubicki · Brigham And Women'S Hospital · R01 · FY2014 · MH

Aging and Estrogenic Control of the Bioenergetic System in Brain

$537,250
Roberta Diaz Brinton · University Of Arizona · R37 · FY2024 · AG

Molecular mechanisms of synapse development and plasticity

$537,177
Zheng Li · National Institute Of Mental Health · ZIA · FY2010 · MH

NHGRI Advanced Imaging & Analysis Core

$537,146
Stephen Wincovitch · National Human Genome Research Institute · ZIC · FY2025 · HG

SARM1 functional polymorphisms and their contribution to ALS risk

$537,074
Adam Joseph Bloom · Washington University · R01 · FY2025 · NS

Single Molecule Approach to Neurodegeneration in Alzheimer's Disease

$536,953
Ari Gafni · University Of Michigan At Ann Arbor · R01 · FY2009 · AG

The pathogenic relationship between neuronal activity and C9orf72-linked neurodegeneration

$536,869
Aaron Raymond Haeusler · Thomas Jefferson University · R01 · FY2024 · NS

High-speed opto-fluidics to screen entire nervous system in aging and disease

$536,740
Adela Ben-Yakar · University Of Texas At Austin · R01 · FY2015 · AG